glp-1-directed nmda receptor antagonism for obesity treatment Caveolae with GLP-1 and Receptors as Crossfire Points the Innovative of Cognitive Dysfunction Associated with Neurodegenerative Diseases The GLP-1 family of drugs
Description
Prado-Alcala R, Streather A, Wise RA (1984)
61 On the other hand, adipocyte inflammation is increased
10-Year follow-up of intensive glucose control in type 2 diabetes
Kidney Inter, Suppl
This review adopts a biopsychosocial perspective to examine how GLP-1 RAs interact with eating behavior, mood, identity, and self-regulation, particularly in individuals with binge eating disorder (BED) or other psychiatric comorbidities
